These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27686941)

  • 1. Carboxymethyl Starch Excipients for Drug Chronodelivery.
    Ispas-Szabo P; De Koninck P; Calinescu C; Mateescu MA
    AAPS PharmSciTech; 2017 Jul; 18(5):1673-1682. PubMed ID: 27686941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
    Assaad E; Mateescu MA
    Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
    Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of drying procedure and of low degree of substitution on the structural and drug release properties of carboxymethyl starch.
    Lemieux M; Gosselin P; Mateescu MA
    AAPS PharmSciTech; 2010 Jun; 11(2):775-85. PubMed ID: 20443088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray-dried high-amylose sodium carboxymethyl starch: impact of α-amylase on drug-release profile.
    Nabais T; Zaraa S; Leclair G
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1887-93. PubMed ID: 27109692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthocyanins Formulated with Carboxymethyl Starch for Gastric and Intestinal Delivery.
    De Sousa Sabino LB; Copes F; Saulais S; De Brito ES; Da Silva Júnior IJ; Le TC; Mateescu MA; Mantovani D
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxymethyl starch: Chitosan monolithic matrices containing diamine oxidase and catalase for intestinal delivery.
    Calinescu C; Mondovi B; Federico R; Ispas-Szabo P; Mateescu MA
    Int J Pharm; 2012 May; 428(1-2):48-56. PubMed ID: 22402476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyelectrolyte complex of carboxymethyl starch and chitosan as protein carrier: oral administration of ovalbumin.
    Assaad E; Blemur L; Lessard M; Mateescu MA
    J Biomater Sci Polym Ed; 2012; 23(13):1713-28. PubMed ID: 21967707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
    Le TC; Mateescu MA
    Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the treatment conditions on the dissolution profile of ethylcellulose coated pellets.
    Pavloková S; Muselík J; Sabadková D; Bernatová S; Samek O; Neumann D; Franc A
    Eur J Pharm Sci; 2019 Apr; 132():86-95. PubMed ID: 30825510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ampholytic starch excipients for high loaded drug formulations: Mechanistic insights.
    Sakeer K; Ispas-Szabo P; Benyerbah N; Mateescu MA
    Int J Pharm; 2018 Jan; 535(1-2):201-216. PubMed ID: 29128422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution.
    Lemieux M; Gosselin P; Mateescu MA
    Int J Pharm; 2009 Dec; 382(1-2):172-82. PubMed ID: 19716866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Stabilizing Ampholytic Starch Excipients for Sustained Release of Highly Soluble Drugs: the Case Study of Metformin.
    Sakeer K; Ispas-Szabo P; Mateescu MA
    AAPS PharmSciTech; 2017 Oct; 18(7):2658-2672. PubMed ID: 28271374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxymethyl-starch excipients for gastrointestinal stable oral protein formulations containing protease inhibitors.
    De Koninck P; Archambault D; Hamel F; Sarhan F; Mateescu MA
    J Pharm Pharm Sci; 2010; 13(1):78-92. PubMed ID: 20456833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxymethyl high amylose starch: Chitosan self-stabilized matrix for probiotic colon delivery.
    Calinescu C; Mateescu MA
    Eur J Pharm Biopharm; 2008 Oct; 70(2):582-9. PubMed ID: 18602991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation of targeted delivery of biological agents using barium sulfate.
    Labelle MA; Ispas-Szabo P; Masseau I; Chorfi Y; Mateescu MA
    Int J Pharm; 2019 Dec; 572():118801. PubMed ID: 31678529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.